Home

drink transmission flow re dual pci trial ppt Previously hide Optimal

RE-DUAL PCI: dual antithrombotic therapy with dabigatran after percutaneous  coronary intervention in patients with atrial fibril
RE-DUAL PCI: dual antithrombotic therapy with dabigatran after percutaneous coronary intervention in patients with atrial fibril

Dual Antithrombotic Therapy in AF Patients Undergoing PCI - Dr. ten B…
Dual Antithrombotic Therapy in AF Patients Undergoing PCI - Dr. ten B…

Dual Antithrombotic Therapy in AF Patients Undergoing PCI - Dr. ten B…
Dual Antithrombotic Therapy in AF Patients Undergoing PCI - Dr. ten B…

The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial  Fibrillation: Design, Rationale, and Status | tctmd.com
The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status | tctmd.com

Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen  after successful coronary stenting in patients with atrial fibrillation  (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet

Atrial Fibrillation and PCI - ppt download
Atrial Fibrillation and PCI - ppt download

Prasugrel-based de-escalation of dual antiplatelet therapy after  percutaneous coronary intervention in patients with acute coronary syndrome  (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority  randomised trial - The Lancet
Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial - The Lancet

Complex Coronary Cases - ppt download
Complex Coronary Cases - ppt download

RE-DUAL PCI: dual antithrombotic therapy with dabigatran after percutaneous  coronary intervention in patients with atrial fibril
RE-DUAL PCI: dual antithrombotic therapy with dabigatran after percutaneous coronary intervention in patients with atrial fibril

Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute  Coronary Syndromes or Percutaneous Intervention | Journal of the American  College of Cardiology
Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention | Journal of the American College of Cardiology

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial  Fibrillation | NEJM
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation | NEJM

Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen  after successful coronary stenting in patients with atrial fibrillation  (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet

Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial  Fibrillation: The RE-DUAL PCI Trial Subanalysis - ScienceDirect
Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis - ScienceDirect

on behalf of the RE-DUAL PCI Steering Committee and Investigators - ppt  download
on behalf of the RE-DUAL PCI Steering Committee and Investigators - ppt download

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial  Fibrillation | NEJM
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation | NEJM

AF and PCI in Practice. - ppt download
AF and PCI in Practice. - ppt download

The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial  Fibrillation: Design, Rationale, and Status - tctmd.com
The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status - tctmd.com

Atrial Fibrillation and PCI - ppt download
Atrial Fibrillation and PCI - ppt download

Anticoagulation in patients with non-valvular AF undergoing PCI: clinical  evidence from PIONEER AF-PCI - The British Journal of Cardiology
Anticoagulation in patients with non-valvular AF undergoing PCI: clinical evidence from PIONEER AF-PCI - The British Journal of Cardiology

on behalf of the RE-DUAL PCI Steering Committee and Investigators - ppt  download
on behalf of the RE-DUAL PCI Steering Committee and Investigators - ppt download

Objectives, The Site, Finance, and Role of The Ethics Committee, Sponsor  and Research Organization
Objectives, The Site, Finance, and Role of The Ethics Committee, Sponsor and Research Organization

Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL  PCI Trial | JACC: Cardiovascular Interventions
Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial | JACC: Cardiovascular Interventions

Atrial Fibrillation and PCI - ppt download
Atrial Fibrillation and PCI - ppt download

AF and PCI in Practice. - ppt download
AF and PCI in Practice. - ppt download

Dual Antithrombotic Therapy in AF Patients Undergoing PCI - Dr. ten B…
Dual Antithrombotic Therapy in AF Patients Undergoing PCI - Dr. ten B…

RE-DUAL PCI™ vs PIONEER AF-PCI™
RE-DUAL PCI™ vs PIONEER AF-PCI™

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups |  tctmd.com
AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups | tctmd.com